Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?
Susan J Lee1, Augusto Paranhos2, M Bruce Shields11Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut, USA; 2Federal University of São Paulo, São Paulo, BrazilPurpose: To evaluate the benefit of titrating the concen...
Guardado en:
Autores principales: | Susan J Lee, Augusto Paranhos, M Bruce Shields |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/751982a5d1e645788260b26c0f816b20 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Risk factors for choroidal detachment after trabeculectomy with mitomycin C
por: Haga A, et al.
Publicado: (2013) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey HM, et al.
Publicado: (2011) -
Corneal lamellar grafting to repair late complications of mitomycin C trabeculectomy
por: Takeo Fukuchi, et al.
Publicado: (2010) -
Long-term Surgical Outcomes of Phacoemulsification with Endoscopic Cyclophotocoagulation vs Phacoemulsification with Trabeculectomy and Mitomycin in Cataract and Glaucoma Patients
por: A Bakr M, et al.
Publicado: (2021) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed AM, et al.
Publicado: (2014)